NXG — NexgenRx Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsAdventurousMicro CapContrarian

Annual balance sheet for NexgenRx, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.527	0.802	2.32	1.77	1.88
Net Total Accounts Receivable
Net Total Receivables	0.313	0.355	0.479	0.41	0.778
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14.5	18.4	20.8	18	23.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.856	0.692	0.504	0.835	0.809
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	21.2	25.2	29.4	25.7	30.2
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.8	19	19.6	16.5	22.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	19.4	19.7	19.7	16.9	22.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1.84	5.52	9.71	8.85	7.71
Total Liabilities & Shareholders' Equity	21.2	25.2	29.4	25.7	30.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding